For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231009:nRSI4421Pa&default-theme=true
RNS Number : 4421P Bloomsbury Publishing PLC 09 October 2023
Bloomsbury playwright Jon Fosse wins Nobel Prize in Literature
9 October, LONDON: Bloomsbury, the leading independent publisher, is pleased
to announce that its author Jon Fosse, the Norwegian playwright, has won the
2023 Nobel Prize in literature "for his innovative plays and prose which give
voice to the unsayable."
According to the citation of the Nobel committee, "his immense oeuvre, written
in Norwegian Nynorsk and spanning a variety of genres consists of a wealth of
plays, novels, poetry collections, essays, children's books and
translations. While he is today one of the most widely performed playwrights
in the world, he has also become increasingly recognised for his prose."
Jon Fosse has won many European awards and in 2007 he was made a Knight in
France's National Order of Merit. He has written 40 plays, performed around
the world in different languages, including the Septology series of novels,
Aliss at the Fire, Melancholy and A Shining.
Winning the 2023 Nobel Prize for Literature, Jon Fosse becomes the 8th
Nobel-Prize winning writer from Bloomsbury's imprint Methuen Drama, joining
Peter Handke, Dario Fo, Toni Morrison, Wole Soyinka, Luigi Pirandello, John
Galsworthy and George Bernard Shaw.
Fosse's first English language play collection was published by Oberon Books,
acquired by Bloomsbury in 2019, which has now published six collections of his
plays, alongside single playtexts including I Am The Wind and The Dead Dogs to
coincide with major premiere productions in London.
Nigel Newton, Chief Executive of Bloomsbury, commented: "Jon Fosse's
remarkable body of dramatic work was fiercely championed by Oberon Books, now
part of Methuen Drama, within the Bloomsbury Academic division, since the
publication of his first English language play collection in 2002. Since then,
we have published five further anthologies, totalling over 30 plays and a
number of standalone translations and adaptations by some of the world's most
successful contemporary dramatists. While he is one of the most-performed
writers in Europe, his dramatic canon is less well-known on U.K. stages and we
hope that with this historic win, the English speaking theatre community will
discover and fall for his unique linguistic style, poetic naturalism and
formally inventive work that manages to be both existential and
life-affirming."
-ENDS-
For further information please contact:
Hudson Sandler +44 (0) 20 7796 4133
Dan de Belder/Emily Brooker bloomsbury@hudsonsandler.com
Bloomsbury Publishing Plc
Bloomsbury is a leading independent publisher of fiction, non-fiction,
children's, specialist, academic and professional titles, listed on the London
Stock Exchange. It is one of the few publishers with a portfolio that includes
both general and academic publishing. Bloomsbury's ambitious growth story has
seen the Group become a significant global publisher with offices in the UK,
US, Australia and India.
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NRAUPGUWUUPWGGB